Method for synthesizing carbetocin in fragment mode
A technology of carbetocin and fragments, which is applied in the field of synthesis of crude carbetocin, can solve the problems of large air resistance of resin amino acids, difficult production operation, and long time consumption, so as to reduce the use of TFA and facilitate industrial production. Effect of improved connection efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment approach
[0046] Embodiment of the present invention: the method for synthesizing carbetocin in fragment mode, comprises the following steps:
[0047] Step (1): Synthesis of fragment Ⅰ [Fmoc-Pro-Leu-Gly-NH2-Rink Amide-AM]:
[0048] The amino resin with Fmoc protection, after de-Fmoc protection, is sequentially synthesized with the pretreated activated amino acids Fmoc-Gly-OH, Fmoc-Leu-OH and Fmoc-Pro-OH with Fmoc protection groups by solid phase synthesis Fragment Ⅰ [Fmoc-Pro-Leu-Gly-NH2-Rink Amide-AM]:
[0049] Specifically, the Fmoc-protected amino resin is added to DCM for swelling, and the swollen resin obtained after filtration is added to a deprotection solution to remove the Fmoc group, and after washing with a washing solution, the amino acid with Fmoc protection activated by pretreatment is sequentially connected by solid-phase synthesis Fmoc-Gly-OH, Fmoc-Leu-OH, Fmoc-Pro-OH;
[0050] Pretreatment activation refers to mixing Fmoc-Gly-OH, Fmoc-Leu-OH, Fmoc-Pro-OH and condensin...
Embodiment 1
[0072] Example 1: Step (1): Synthesis of Fragment I [Fmoc-Pro-Leu-Gly-NH2-Rink Amide-AM]:
[0073] The amino resin with Fmoc protection, after de-Fmoc protection, is sequentially synthesized with the pretreated activated amino acids Fmoc-Gly-OH, Fmoc-Leu-OH and Fmoc-Pro-OH with Fmoc protection groups by solid phase synthesis Fragment Ⅰ [Fmoc-Pro-Leu-Gly-NH2-Rink Amide-AM]:
[0074] Specifically, the Fmoc-protected amino resin is added to DCM for swelling, and the swollen resin obtained after filtration is added to a deprotection solution to remove the Fmoc group, and after washing with a washing solution, the amino acid with Fmoc protection activated by pretreatment is sequentially connected by solid-phase synthesis Fmoc-Gly-OH, Fmoc-Leu-OH, Fmoc-Pro-OH;
[0075] Pretreatment activation refers to mixing Fmoc-Gly-OH, Fmoc-Leu-OH, Fmoc-Pro-OH and condensing agent respectively, dissolving them in DMF, and activating them for use.
[0076] Further, the deprotection solution is a...
Embodiment 2
[0095] Example 2: Step (1): Synthesis of Fragment I [Fmoc-Pro-Leu-Gly-NH2-Rink Amide-AM]:
[0096] The amino resin with Fmoc protection, after de-Fmoc protection, is sequentially synthesized with the pretreated activated amino acids Fmoc-Gly-OH, Fmoc-Leu-OH and Fmoc-Pro-OH with Fmoc protection groups by solid phase synthesis Fragment Ⅰ [Fmoc-Pro-Leu-Gly-NH2-Rink Amide-AM]:
[0097] Specifically, the Fmoc-protected amino resin is added to DCM for swelling, and the swollen resin obtained after filtration is added to a deprotection solution to remove the Fmoc group, and after washing with a washing solution, the amino acid with Fmoc protection activated by pretreatment is sequentially connected by solid-phase synthesis Fmoc-Gly-OH, Fmoc-Leu-OH, Fmoc-Pro-OH;
[0098] Pretreatment activation refers to mixing Fmoc-Gly-OH, Fmoc-Leu-OH, Fmoc-Pro-OH and condensing agent respectively, dissolving them in DMF, and activating them for use.
[0099] Further, the deprotection solution is a...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 

